Sign up to save your podcasts
Or
Share Proactive Adverse Effect Management in mCRC: Improving Tolerability to Optimize Patient Outcomes
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Proactive Adverse Effect Management in mCRC: Improving Tolerability to Optimize Patient Outcomes
CME credits: 1.00
Valid until: 02-12-2026
Claim your CME credit at https://reachmd.com/programs/cme/ProactiveAdverseEffectManagementinmCRCImprovingTolerabilitytoOptimizePatientOutcomes/32945/
This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 1.00
Valid until: 02-12-2026
Claim your CME credit at https://reachmd.com/programs/cme/ProactiveAdverseEffectManagementinmCRCImprovingTolerabilitytoOptimizePatientOutcomes/32945/
This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.